Objetivo: desenvolver e validar cartilhas para aprimorar o preparo e a utilização de insulinas, bem como o monitoramento da glicemia capilar. Métodos: as cartilhas foram elaboradas considerando a acessibilidade das informações e a compreensibilidade das imagens, a fim de torná-las didáticas ao público-alvo. Posteriormente, foram submetidas à validação. Resultados: por meio da Técnica Delphi, criou-se um questionário contendo 10 perguntas para cada uma das quatro cartilhas validadas, o qual foi enviado para 32 painelistas, especialistas na área. A fim de avaliar o consenso entre as respostas dos painelistas, em cada item, empregou-se o cálculo do Coeficiente de Validade de Conteúdo (CVC), que varia de 0 a 1. Considerou-se validado, o valor de CVC superior a 0,8. Ao final de duas rodadas, foi possível validar as quatro cartilhas. Conclusão: o material possui vasto potencial de contribuição para o uso racional, efetivo e seguro das insulinas, além de poder contribuir com a qualidade de vida dos pacientes e com a redução de custos para o sistema de saúde.

No abstract

Cosmetic products are essential items in everyday life and directly related to a good quality of life. This branch has been steadily growing in Brazilian market even in the midst of the economic crisis. Thence, it is the role of the Brazilian National Health Surveillance Agency (Anvisa) to establish standards, guidelines and surveillance actions in relation to these products. In this work, we therefore aimed to perform the descriptive analysis of cosmetics which were considered by Anvisa as irregular products between 2009 and 2020. Results were evaluated according to the following attributes: companies; motives; products; and inspection actions. The analysis encompassed a total of 872 notifications, which showcased that the majority of companies with irregular products are located in the Southeast region (64%), mainly in São Paulo. There was an expressive degree of recurrence of the notified companies, which together were responsible for 40% of the total withdrawals. The most frequent motivations for the application of sanctions were: the absence of product registration/notification (35.3%); quality deviations (25.9%); and the lack of a business license (20.0 %). The most commonly withdrawn products were those for hair use, which may indicate strong relation with the use in beauty salons. In addition, there was a large increase in the irregularity of antiseptic gels in 2020. The number of revocations was low, what suggests lack of adequate quality management in the notified companies. In conclusion, Anvisa has fulfilled its institutional objective of standardization, thereby establishing and enforcing adequate product safety countrywide.

No abstract

Background Studies show that among the drugs most commonly used in judicial litigation in Brazil, are those used to treat diabetes mellitus, especially insulin analogues. Objective Evaluate the use of the Unified Health System (SUS) by patients with type 1 diabetes mellitus (T1DM), who receive insulin analogues through judicial action, before and after this process. Method In a retrospective longitudinal observational study, secondary data was used from these patients in Minas Gerais, Brazil, in 2018. Socio-demographic information was collected and related to the follow-up of these patients in the SUS. The McNemar χ2 test was used to compare the proportions of the variables. Results Of the 89 patients analyzed, women (53.9%) were predominant. Most patients were aged between 20 and 39 years (52.8%), and more than half, 55.1%, use only a private health system. After the judicial action, there was a significant increase (p <0.05) in the number of patients who had consultations in primary health care (from 19.1% to 30.3%) and emergency medical appointments (from 1.1% to 9.0%). Conclusion It is observed that the majority of patients with T1DM via judicial action in the SUS are not monitored by this health system through examinations, consultations, and hospitalizations.